ArticleScientific reports2025
Plasma synthesis of rhenium nanoparticles as an efficient alternative to platinum nanoparticles for nitroaromatic compound hydrogenations.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Rhenium nanoparticles are an attractive alternative to noble metal-based approaches, which show a limited applicability. The catalytic potential and environmental impact of rhenium nanoparticles (ReNPs) were assessed in conjunction with those of platinum nanoparticles (PtNPs). Both of these nanomaterials were synthesized via low-cost pulse-modulated radiofrequency atmospheric pressure glow discharge (pm-rf-APGD). In this context, pm-rf-APGD was used for the first time to synthesize Re-based nanomaterials. The obtained nanoparticles were used as nanocatalysts for hydrogenation of nitroaromatic compounds. Subsequent characterization revealed high efficacy of rhenium nanoparticles in catalysing the reduction of nitroaromatic compounds, which reached up to 100% conversion yields at a rate constant k
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.